|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 555.4 USD | +1.97% |
|
+4.43% | +4.64% |
| 07-16 | Orthofix Names Stephanie Walsh as Chief Human Resources Officer | CI |
| 07-11 | Thermo Fisher Scientific Keeps Quarterly Cash Dividend at $0.39 Per Share, Payable Oct. 15 to Holders as of Sept. 13 | MT |
Jan 31 (Reuters) - Medical equipment maker Thermo Fisher Scientific Inc on Wednesday forecast annual profit below Wall Street estimates, as it expects that a slump in demand for its services used to make therapeutics and vaccines to continue this year.
The company forecast adjusted profit between $20.95 to $22.00 per share in 2024.
Analysts were expecting a profit of $22.04 per share in 2024.
(Reporting by Bhanvi Satija in Bengaluru; Editing by Maju Samuel)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 2,918 PTS | +0.45% | +0.30% | - | ||
| 555.4 USD | +1.97% | +4.43% | 208B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +4.64% | 208B | |
| +8.99% | 182B | |
| +29.83% | 155B | |
| +35.17% | 115B | |
| +2.55% | 66.52B | |
| +15.06% | 53.93B | |
| -6.47% | 46.26B | |
| -2.14% | 38.22B | |
| +6.88% | 36.6B | |
| +20.22% | 30.16B |
THERMO FISHER SCIENTIFIC 
